Cart
sales@molnova.com
4-Amino-5-Bromopyrrolo[2,3-D]Pyrimidine
CAS No. 22276-99-9
4-Amino-5-Bromopyrrolo[2,3-D]Pyrimidine( 5-bromo-1H-pyrrolo[2,3-d]pyrimidin-4-amine | )
Catalog No. M29555 CAS No. 22276-99-9
4-Amino-5-Bromopyrrolo[2,3-D]Pyrimidine is a marine derived natural products found in Echinodictyum sp.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 55 | In Stock |
|
| 5MG | 48 | In Stock |
|
| 10MG | 71 | In Stock |
|
| 25MG | 122 | In Stock |
|
| 50MG | 179 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name4-Amino-5-Bromopyrrolo[2,3-D]Pyrimidine
-
NoteResearch use only, not for human use.
-
Brief Description4-Amino-5-Bromopyrrolo[2,3-D]Pyrimidine is a marine derived natural products found in Echinodictyum sp.
-
Description4-Amino-5-Bromopyrrolo[2,3-D]Pyrimidine is a marine derived natural products found in Echinodictyum sp.
-
In Vitro——
-
In Vivo——
-
Synonyms5-bromo-1H-pyrrolo[2,3-d]pyrimidin-4-amine |
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number22276-99-9
-
Formula Weight213.04
-
Molecular FormulaC6H5BrN4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESBrC1=CNC=2N=CN=C(N)C12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Albiflorin
Albiflorin and paeoniflorin has neuroprotective action against Glu toxicity.
-
Granuliberin R
Granuliberin R is a new mast cell degranulating peptide comes from amphibian, can be isolated from the skin of frog Rana rugosa. Granuliberin R is a dodecapeptide, can act on rat peritoneal mast cell to liberate granules and release histamine.
-
Anle138b
Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson’s disease.
